BackSanofi India’s Q2 net rises 12.30% at to Rs57.5 crore
Net sales rise 18.70% to Rs486.7 crore; Sanofi India board recommends interim dividend of Rs10 per equity share
Premium
New Delhi: Drug firm Sanofi India has reported 12.30% increase in its net profit at ₹ 57.5 crore for the second quarter ended 30 June 2014. The company had posted a net profit of ₹ 51.2 crore during the same period last year.
Net sales of the company went up by 18.70% to 486.7 crore during the quarter under review as against 410 crore during the same period a year ago, Sanofi India said in a BSE filing.
Overall expenses stood at ₹ 431.9 crore in the quarter as against ₹ 370.4 crore in the corresponding period of the previous year.
The company’s board, which met on Wednesday, recommended an interim dividend of ₹ 10 per equity share.
Shares of Sanofi India on Wednesday closed at ₹ 2939.50 apiece on the BSE, down 1.24% from their previous close.
Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!
